Cost-effectiveness of health promotion targeting physical activity and healthy eating in mental health care

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Verhaeghe, Nick ^a,b   De Smedt, Delphine ^a   De Maeseneer, Jan ^a   Maes, Lea ^a   Van Heeringen, Cornelis ^a   Annemans, Lieven ^a,b  

^a GHENT UNIVERSITY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Cost effectiveness; Health promotion; Healthy eating; Mental disorders; Physical activity

Indexed keywords

ADULT; AGED; BODY MASS; COMPLICATION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIET; ECONOMICS; EXERCISE; FEMALE; HEALTH BEHAVIOR; HEALTH PROMOTION; HUMAN; MALE; MENTAL DISEASE; MENTAL HEALTH; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; PROBABILITY; PROGRAM EVALUATION; PSYCHOLOGY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; UNCERTAINTY; WEIGHT LOSS PROGRAM; YOUNG ADULT;

ADULT; AGED; BODY MASS INDEX; COST-BENEFIT ANALYSIS; DIET; EXERCISE; FEMALE; HEALTH BEHAVIOR; HEALTH PROMOTION; HUMANS; MALE; MARKOV CHAINS; MENTAL DISORDERS; MENTAL HEALTH; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; PROGRAM EVALUATION; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; UNCERTAINTY; WEIGHT REDUCTION PROGRAMS; YOUNG ADULT;

EID: 84906927511     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-856     Document Type: Article

References (53)

1. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M, Lancet 2011 377 557 567 10.1016/S0140-6736(10)62037-5 21295846
2. Obesity. Haslam DW, James WP, Lancet 2005 366 1197 1209 10.1016/S0140-6736(05)67483-1 16198769
3. Health-economic burden of obesity in Europe. Muller-Riemenschneider F, Reinhold T, Berghofer A, Willich SN, Eur J Epidemiol 2008 23 499 509 10.1007/s10654-008-9239-1 18509729
4. Meta-analysis of the association between body mass index and health-related quality of life among adults, assessed by the SF-36. Ul-Haq Z, Mackay DF, Pell JP, Obesity 2013 21 322 E327 10.1002/oby.20107 23592685
5. The effect of obesity on health outcomes. Dixon JB, Mol Cell Endocrinol 2010 316 104 108 10.1016/j.mce.2009.07.008 19628019
6. Obesity among those with mental disorders: a National Institute of Mental Health meeting report. Allison DB, Newcomer JW, Dunn AL, Blumenthal JA, Fabricatore AN, Daumit GL, Cope MB, Riley WT, Vreeland B, Hibbeln JR, Alpert JE, Am J Prev Med 2009 36 341 350 10.1016/j.amepre.2008.11.020 19285199
7. Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community. Mackin P, Bishop D, Watkinson H, Gallagher P, Ferrier IN, Br J Psychiatry 2007 191 23 29 10.1192/bjp.bp.106.031716 17602121
8. Weight effects associated with antipsychotics: a comprehensive database analysis. Parsons B, Allison DB, Loebel A, Williams K, Giller E, Romano S, Siu C, Schizophr Res 2009 110 103 110 10.1016/j.schres.2008.09.025 19321312
9. Physical activity, dietary habits and Coronary Heart Disease risk factor knowledge amongst people with severe mental illness: a cross sectional comparative study in primary care. Osborn DP, Nazareth I, King MB, Soc Psychiatry Psychiatr Epidemiol 2007 42 787 793 10.1007/s00127-007-0247-3 17721669
10. A program for treating olanzapine-related weight gain. Ball MP, Coons VB, Buchanan RW, Psychiatr Serv 2001 52 967 969 10.1176/appi.ps.52.7.967 11433117
11. A psychoeducational program for weight loss in patients who have experienced weight gain during antipsychotic treatment with olanzapine. Mauri M, Simoncini M, Castrogiovanni S, Iovieno N, Cecconi D, Dell'Agnello G, Quadrigli M, Rossi A, Donda P, Fagiolini P, Cassano GB, Pharmacopsychiatry 2008 41 17 23 10.1055/s-2007-992148 18203047
12. Are physical activity interventions in primary care and the community cost-effective? A systematic review of the evidence. Garrett S, Elley CR, Rose SB, O'Dea D, Lawton BA, Dowell AC, Br J Gen Pract 2011 61 125 e133 10.3399/bjgp11X561249 21375895
13. Cost-effectiveness of a low-calorie diet and orlistat for obese persons: modeling long-term health gains through prevention of obesity-related chronic diseases. van Baal PH, van den Berg M, Hoogenveen RT, Vijgen SM, Engelfriet PM, Value Health 2008 11 1033 1040 10.1111/j.1524-4733.2008.00328.x 18494748
14. Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: a systematic review. Verhaeghe N, De MJ, Maes L, Van HC, Annemans L, Int J Behav Nutr Phys Act 2011 8 28 10.1186/1479-5868-8-28 21481247
15. Health promotion in individuals with mental disorders: a cluster preference randomized controlled trial. Verhaeghe N, Clays E, Vereecken C, De Maeseneer J, Maes L, Van Heeringen C, De Bacquer D, Annemans L, BMC Public Health 2013 13 657 10.1186/1471-2458-13-657 23855449
16. Manual Health Promotion: Healthy eating and physical activity. Flemish Institute of Health Promotion and Disease Prevention, 2007 http://www.vigez.be
17. A cost-effectiveness study of the community-based intervention '10 000 Steps Ghent'. De Smedt D, De Cocker K, Annemans L, De Bourdeaudhuij I, Cardon G, Public Health Nutr 2012 15 442 451 10.1017/S1368980011001716 21859505
18. Flemish Agency for Care and Health, Chronic Diseases: Incidence and Prevalence Brussels: Flemish Agency for Care and Health 2010 http://www.zorg-en-gezondheid.be/Cijfers/Cijfers-over-zorgaanbod/Artsen/
19. Nationaal Kompas Volksgezondheid. Rijksinstituut voor Volksgezondheid en Milieu, 2007 http://www.nationaalkompas.nl/gezondheid-en-ziekte/
20. Registratienetwerk van huisartsen in Vlaanderen. Intego, 2010 http://intego.be/nl/Welkom
21. Tabellen op jaarbasis. Belgian Cancer Registry, 2010 http://www.kankerregister.org/
22. Incident somatic comorbidity after psychosis: results from a retrospective cohort study based on Flemish general practice data. Truyers C, Buntinx F, De LJ, De HM, van Winkel R, Aertgeerts B, Bartholomeeusen S, Lesaffre E, BMC Fam Pract 2011 12 132 10.1186/1471-2296-12-132 22126584
23. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Rsearch Database. Osborn DP, Levy G, Nazareth I, Petersen I, Islam A, King MB, Arch Gen Psychiatry 2007 64 242 249 10.1001/archpsyc.64.2.242 17283292
24. Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study. Hippisley-Cox J, Vinogradova Y, Coupland C, Parker C, Arch Gen Psychiatry 2007 64 1368 1376 10.1001/archpsyc.64.12.1368 18056544
25. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. Larsson SC, Orsini N, Wolk A, J Natl Cancer Inst 2005 97 1679 1687 10.1093/jnci/dji375 16288121
26. Statistics Belgium. http://statbel.fgov.be/nl/statistieken/cijfers/. 2010. Brussels, Statistics Belgium. 2012
27. Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in The Netherlands (ZODIAC-1). Ubink-Veltmaat LJ, Bilo HJ, Groenier KH, Houweling ST, Rischen RO, Meyboom-de JB, Eur J Epidemiol 2003 18 793 800 12974556
28. The dynamics of mortality in follow-up time after an acute myocardial infarction, lower extremity arterial disease and ischemic stroke. Vaartjes I, van Dis I, Grobbee DE, Bots ML, BMC Cardiovasc Disord 2010 10 57 10.1186/1471-2261-10-57 21106115
29. Belgian Cancer Registry, Cancer Survival in Belgium 2004-2008 Brussels: Belgian Cancer Registry 2012
30. Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Schienkiewitz A, Schulze MB, Hoffmann K, Kroke A, Boeing H, Am J Clin Nutr 2006 84 427 433 16895894
31. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. McGee DL, Ann Epidemiol 2005 15 87 97 10.1016/j.annepidem.2004.05.012 15652713
32. Body mass index and the risk of stroke in men. Kurth T, Gaziano JM, Berger K, Kase CS, Rexrode KM, Cook NR, Buring JE, Manson JE, Arch Intern Med 2002 162 2557 2562 10.1001/archinte.162.22.2557 12456227
33. Body mass index, coronary heart disease and stroke in Swedish women. A prospective 19-year follow-up in the BEDA study. Rosengren A, Wilhelmsen L, Lappas G, Johansson S, Eur J Cardiovasc Prev Rehabil 2003 10 443 450 10.1097/01.hjr.0000085253.65733.ef 14671467
34. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M, Lancet 2008 371 569 578 10.1016/S0140-6736(08)60269-X 18280327
35. Assessing the impact of complications on the costs of Type II diabetes. Williams R, Van GL, Lucioni C, Diabetologia 2002 45 13 S17 10.1007/s00125-002-0859-9 12136406
36. Health economic evaluation of controlled and maintained physical exercise in the prevention of cardiovascular and other prosperity diseases. Annemans L, Lamotte M, Clarys P, Van den Abeele E, Eur J Cardiovasc Prev Rehabil 2007 14 815 824 10.1097/HJR.0b013e3282ef514f 18043305
37. Cost effectiveness of atorvastatin in patients with type 2 diabetes mellitus: a pharmacoeconomic analysis of the collaborative atorvastatin diabetes study in the belgian population. Annemans L, Marbaix S, Webb K, Van GL, Scheen A, Clin Drug Investig 2010 30 133 142 10.2165/11531910-000000000-00000 20067331
38. Assessment of the cost of cardiovascular death. Lamotte M, Caekelbergh K, Annemans L, Value Health 2003 6 658
39. Cleemput I, Crott R, Vrijens F, Huybrechts M, Van Wilder P, Ramaekers D, Voorlopige Richtlijnen voor Farmaco-economisch Onderzoek in België. Health Technology Assessment (HTA), KCE Report 28A (D/2006/10.273/10) edn Brussels: Belgian Health Care Knowledge Centre (KCE) 2006
40. Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. Saarni SI, Viertio S, Perala J, Koskinen S, Lonnqvist J, Suvisaari J, Br J Psychiatry 2010 197 386 394 10.1192/bjp.bp.109.076489 21037216
41. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL, Methods for the Economic Evaluation of Health Care Programmes Oxford: Oxford University Press 3 2005
42. Valuing health-related quality of life in diabetes. Coffey JT, Brandle M, Zhou H, Marriott D, Burke R, Tabaei BP, Engelgau MM, Kaplan RM, Herman WH, Diabetes Care 2002 25 2238 2243 10.2337/diacare.25.12.2238 12453967
43. Briggs A, Claxton K, Sculpher M, Decision Modelling for Health Economic Evaluation Oxford: Oxford University Press 2006
44. Cleemput I, Neyt M, Thiry N, De Laet C, Leys M, Threshold Values for Cost-Effectiveness in Health Care. Health Technology Assessment (HTA). KCE Report 100C (D/2008/10.273/96) edn Brussels: Belgian Health Care Knowledge Centre (KCE) 2008
45. Perceptions of barriers and benefits to physical activity among outpatients in psychiatric rehabilitation. McDevitt J, Snyder M, Miller A, Wilbur J, J Nurs Scholarsh 2006 38 50 55 10.1111/j.1547-5069.2006.00077.x 16579324
46. Clinical trial-based cost-effectiveness analyses of antipsychotic use. Polsky D, Doshi JA, Bauer MS, Glick HA, Am J Psychiatry 2006 163 2047 2056 10.1176/appi.ajp.163.12.2047 17151153
47. Is it worth investing in mental health promotion and prevention of mental illness? A systematic review of the evidence from economic evaluations. Zechmeister I, Kilian R, McDaid D, BMC Public Health 2008 8 20 10.1186/1471-2458-8-20 18211677
48. Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. Menza M, Vreeland B, Minsky S, Gara M, Radler DR, Sakowitz M, J Clin Psychiatry 2004 65 471 477 15119908
49. The long-term effectiveness of a lifestyle intervention in severely obese individuals. Unick JL, Beavers D, Bond DS, Clark JM, Jakicic JM, Kitabchi AE, Knowler WC, Wadden TE, Wagenknecht LE, Wing RR, Am J Med 2013 126 236 242 10.1016/j.amjmed.2012.10.010 23410564
50. The efficacy and cost-effectiveness of a community weight management intervention: a randomized controlled trial of the health weight management demonstration. Hersey JC, Khavjou O, Strange LB, Atkinson RL, Blair SN, Campbell S, Hobbs CL, Kelly B, Fitzgerald TM, Kish-Doto J, Koch MA, Munoz B, Peele E, Stockdale J, Augustine C, Mitchell G, Arday D, Kugler J, Dorn P, Ellzy J, Julian R, Grissom J, Britt M, Prev Med 2012 54 42 49 10.1016/j.ypmed.2011.09.018 22001689
51. Microvascular and macrovascular complications of diabetes. Fowler MJ, Clin Diab 2008 26 77 82 10.2337/diaclin.26.2.77
52. The EQ-5D: A useful quality of life measure in borderline personality disorder? van Asselt AD, Dirksen CD, Arntz A, Giesen-Bloo JH, Severens JL, Eur Psychiatry 2009 24 79 85 10.1016/j.eurpsy.2008.11.001 19095421
53. Comparison of EQ-5D and SF-6D utilities in mental health patients. Lamers LM, Bouwmans CA, van Straten A, Donker MC, Hakkaart L, Health Econ 2006 15 1229 1236 10.1002/hec.1125 16625671